Fatty-Acid-Based Membrane Lipidome Profile of Peanut Allergy Patients: An Exploratory Study of a Lifelong Health Condition

peanut allergy is a lifelong, increasingly prevalent, and potentially life-threatening disease burdening families and communities. dietary, particularly polyunsaturated fatty acids (PUFAs), intakes can exert positive effects on immune and inflammatory responses, and the red blood cell (RBC) membrane lipidome contains stabilized metabolic and nutritional information connected with such responses. the fatty-acid-based membrane lipidome profile has been exploratorily evaluated in a small cohort of patients (eight males and one female, age range 4.1-21.7 years old, body mass index BMI < 25) with angioedema and/or anaphylaxis after peanut ingestion. this analysis was performed according to an ISO 17025 certified robotic protocol, isolating mature RBCs, extracting membrane lipids, and transforming them to fatty acid methyl esters for gas chromatography recognition and quantification. comparison with a group of age- and BMI-matched healthy individuals and with benchmark interval values of a healthy population evidenced significant differences, such as higher levels of omega-6 (arachidonic acid), lower values of omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), together with an increased omega-6/omega-3 ratio in allergic patients. a significant inverse correlation was also found between specific immunoglobulin E (IgE) levels and omega-6 di-homo-gamma-linolenic acid (DGLA) and total PUFAs. results of this preliminary study encourage screenings in larger cohorts, also in view of precision nutrition and nutraceuticals strategies, and stimulate interest to expand basic and applied research for unveiling molecular mechanisms that are still missing and individuating treatments in chronic allergic disorders.